Catalent Inc (NASDAQ:CTLT) was downgraded by investment analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Friday.

Other equities research analysts also recently issued reports about the company. Bank of America Corporation reissued a “buy” rating and issued a $38.00 target price (up from $37.00) on shares of Catalent in a report on Friday, July 21st. Zacks Investment Research raised Catalent from a “sell” rating to a “buy” rating and set a $39.00 target price on the stock in a report on Tuesday, July 4th. J P Morgan Chase & Co reissued a “buy” rating and issued a $40.00 target price on shares of Catalent in a report on Tuesday, August 29th. Piper Jaffray Companies reissued a “buy” rating and issued a $45.00 target price on shares of Catalent in a report on Tuesday, August 29th. Finally, ValuEngine raised Catalent from a “hold” rating to a “buy” rating in a report on Thursday, September 7th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $36.80.

Shares of Catalent (CTLT) opened at 40.27 on Friday. Catalent has a one year low of $21.83 and a one year high of $42.22. The company has a 50-day moving average price of $36.80 and a 200 day moving average price of $33.45. The company has a market capitalization of $5.04 billion and a PE ratio of 46.29.

Catalent (NASDAQ:CTLT) last released its earnings results on Monday, August 28th. The company reported $0.65 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.08. Catalent had a return on equity of 16.95% and a net margin of 4.88%. The business had revenue of $616.90 million for the quarter, compared to the consensus estimate of $547.48 million. During the same period in the previous year, the company posted $0.52 earnings per share. The company’s revenue for the quarter was up 15.9% compared to the same quarter last year. Equities analysts anticipate that Catalent will post $1.61 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece on another site, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The original version of this piece can be read at https://www.dailypolitical.com/2017/09/14/bidaskclub-lowers-catalent-inc-ctlt-to-hold.html.

In other news, SVP Christine Dolan sold 745 shares of the company’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $34.85, for a total transaction of $25,963.25. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Several large investors have recently made changes to their positions in CTLT. Flinton Capital Management LLC lifted its holdings in shares of Catalent by 17.7% during the first quarter. Flinton Capital Management LLC now owns 3,616 shares of the company’s stock valued at $102,000 after purchasing an additional 544 shares in the last quarter. Acrospire Investment Management LLC lifted its holdings in shares of Catalent by 72.2% during the second quarter. Acrospire Investment Management LLC now owns 3,100 shares of the company’s stock valued at $109,000 after purchasing an additional 1,300 shares in the last quarter. Quantbot Technologies LP lifted its holdings in shares of Catalent by 110.7% during the second quarter. Quantbot Technologies LP now owns 3,434 shares of the company’s stock valued at $120,000 after purchasing an additional 1,804 shares in the last quarter. Meadow Creek Investment Management LLC lifted its holdings in shares of Catalent by 17.7% during the first quarter. Meadow Creek Investment Management LLC now owns 4,972 shares of the company’s stock valued at $141,000 after purchasing an additional 748 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its holdings in shares of Catalent by 115.7% during the first quarter. Acadian Asset Management LLC now owns 5,847 shares of the company’s stock valued at $166,000 after purchasing an additional 3,136 shares in the last quarter.

About Catalent

Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.

Analyst Recommendations for Catalent (NASDAQ:CTLT)

Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.